X0202 SCHEDULE 13G/A 0002036836 XXXXXXXX LIVE 2 Common Shares, no par value per share 02/09/2026 0001892500 Clearmind Medicine Inc. 185053402 101 - 1220 West 6th Avenue Vancouver A1 V6H1A5 Rule 13d-1(c) Capitalink Ltd. b L3 107943.00 0.00 107943.00 0.00 107943.00 N 5.0 CO *Percentage calculated based on 2,088,806 common shares, no par value per share, of Clearmind Medicine Inc. (the "Issuer") issued and outstanding as of the reporting date, which amount was provided to the Reporting Person by the Issuer. Clearmind Medicine Inc. 101 - 1220 West 6th Avenue, Vancouver, BRITISH COLUMBIA, CANADA, V6H1A5. Capitalink Ltd. 20 Raoul Wallenberg Street, Tel Aviv, Israel 6971916 Israel Y See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein. Amount beneficially owned by the Reporting Person consists of (i) 32,693 Common Shares and (ii) 93,231 Common Shares issuable upon the conversion of a convertible promissory note (the "Note") in the aggregate principial amount of $116,538.50, including the accrued interest thereon, assuming a conversion price of $1.25, the floor price of the Note, which may be acquired by the Reporting Person within 60 days of the date hereof through the conversion of the Note, and (iii) 229,000 Common Shares which may be acquired by the Reporting Person within 60 days of the date hereof through the exercise of a pre-funded warrant (the "Warrant"). The Note and the Warrant each include a blocker provision under which the Reporting Person does not have the right to exercise the Warrant or convert the Note, respectively, to the extent (but only to the extent) that such exercise or conversion would result in beneficial ownership by the Reporting Person, together with the Reporting Person's affiliates, and any other persons acting as a group together with the Reporting Person or any of the Reporting Person's affiliates, of more than 4.99% of the Ordinary Shares. See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein. See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein. See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein. See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein. See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Capitalink Ltd. /s/ Lavi Krasney 03/16/2026